Piper Jaffray adds Mindray Medical (NYSE: MR) to the Alpha List, reiterating a Buy rating and $46 PT.

Piper ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE